Joseph Fennelly1, Lauren Potter1, Cecilia Pompili2, Alessandro Brunelli1. 1. Department of Thoracic Surgery, St. James's University Hospital, Leeds, UK. 2. Section of Patient Centered Outcomes Research, Leeds Institute of Cancer and Pathology, Leeds, UK.
Abstract
BACKGROUND: The current functional guidelines recommend the shuttle walk test (SWT) as an initial screening tool to identify candidates for lung resection without requiring cardiopulmonary exercise testing. This study aims to: (I) assess the use of the SWT in predicting postoperative cardiopulmonary complications; and (II) determine whether the recommended 400 m cut-off is an appropriate distance. METHODS: We retrospectively analysed 101 patients that had performed a SWT prior to surgery. Univariate and multivariate regression analyses were used to test associations between patient variables [demographics, pre-existing conditions, pulmonary function, oxygen desaturation during the SWT, shuttle walk distance (SWD)] and post-operative cardiopulmonary complications. RESULTS: Patients without cardiopulmonary complications walked longer distance compared to those with complication (417.3 vs. 348.6 m, P=0.01. Fifty two patients walked less than 400 m and 16 less than 250 m. Only 10% of patients who walked at least 400 m had cardiopulmonary complications compared to 33% of those who did not reach this distance (P=0.008). Half of the patients who walked less than 400 m and desaturated during the exercise developed cardiopulmonary complications. A SWD shorter than 400 m remained the only factor significantly associated with cardiopulmonary complications (P=0.009, OR: 4.3) after logistic regression analysis. CONCLUSIONS: Our results support the use of the SWT as an initial screening tool in all patients prior to lung resection. Patients walking longer than 400 m experienced very low incidence of complications and would not need further testing prior to proceed to lung resection.
BACKGROUND: The current functional guidelines recommend the shuttle walk test (SWT) as an initial screening tool to identify candidates for lung resection without requiring cardiopulmonary exercise testing. This study aims to: (I) assess the use of the SWT in predicting postoperative cardiopulmonary complications; and (II) determine whether the recommended 400 m cut-off is an appropriate distance. METHODS: We retrospectively analysed 101 patients that had performed a SWT prior to surgery. Univariate and multivariate regression analyses were used to test associations between patient variables [demographics, pre-existing conditions, pulmonary function, oxygen desaturation during the SWT, shuttle walk distance (SWD)] and post-operative cardiopulmonary complications. RESULTS:Patients without cardiopulmonary complications walked longer distance compared to those with complication (417.3 vs. 348.6 m, P=0.01. Fifty two patients walked less than 400 m and 16 less than 250 m. Only 10% of patients who walked at least 400 m had cardiopulmonary complications compared to 33% of those who did not reach this distance (P=0.008). Half of the patients who walked less than 400 m and desaturated during the exercise developed cardiopulmonary complications. A SWD shorter than 400 m remained the only factor significantly associated with cardiopulmonary complications (P=0.009, OR: 4.3) after logistic regression analysis. CONCLUSIONS: Our results support the use of the SWT as an initial screening tool in all patients prior to lung resection. Patients walking longer than 400 m experienced very low incidence of complications and would not need further testing prior to proceed to lung resection.
Entities:
Keywords:
Shuttle walk test (SWT); complications; exercise test; lung cancer; lung surgery
Authors: Eric Lim; David Baldwin; Michael Beckles; John Duffy; James Entwisle; Corinne Faivre-Finn; Keith Kerr; Alistair Macfie; Jim McGuigan; Simon Padley; Sanjay Popat; Nicholas Screaton; Michael Snee; David Waller; Chris Warburton; Thida Win Journal: Thorax Date: 2010-10 Impact factor: 9.139
Authors: A Brunelli; A Charloux; C T Bolliger; G Rocco; J-P Sculier; G Varela; M Licker; M K Ferguson; C Faivre-Finn; R M Huber; E M Clini; T Win; D De Ruysscher; L Goldman Journal: Eur Respir J Date: 2009-07 Impact factor: 16.671
Authors: Felix G Fernandez; Pierre E Falcoz; Benjamin D Kozower; Michele Salati; Cameron D Wright; Alessandro Brunelli Journal: Ann Thorac Surg Date: 2015-01 Impact factor: 4.330
Authors: Thida Win; Arlene Jackson; Ashley M Groves; Francis C Wells; Andrew J Ritchie; Helen Munday; Clare M Laroche Journal: Eur J Cardiothorac Surg Date: 2004-12 Impact factor: 4.191